Actavis completes deal to buy Forest Labs

8:31 AM ET Tue, 1 July 2014

The idea is to keep the generic DNA but not the generic margins, says Brent Saunders, Actavis CEO, discussing his company's acquisition of Forest Labs and its long-term growth plans. Saunders also weighs in on corporate tax reform.